A Pilot Clinical Trial of Cell Therapy in Heart Failure with Preserved Ejection Fraction

Scientists investigated the effects of CD34+ cell therapy in patients with heart failure with preserved ejection fraction.
[European Journal of Heart Failure]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News